comparemela.com

Latest Breaking News On - Endpoints news - Page 17 : comparemela.com

VESSELON TOWN HALL EVENT PROVIDES A GLIMPSE INTO THE FUTURE OF INTRAVENOUS DRUG DEVELOPMENT

VESSELON TOWN HALL EVENT PROVIDES A GLIMPSE INTO THE FUTURE OF INTRAVENOUS DRUG DEVELOPMENT
kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

Clay larsenJoe truittOneil edwardsVesselon incSecure incCo founder clay larsenEndpoints news

Five things for pharma marketers to know: Friday, September 1, 2023

Gene-editing biotech Metagenomi is preparing to go public; In light of Hurricane Idalia’s landfall, the CDC reminds people of floodwater health risks.

United statesEli lillyDavid ricksMike penceElection commissionCenters for diseaseEndpoints newsHurricane idaliaDisease controlVice president mike penceFederal election commissionIndy star

Despite 12 Infant Deaths During Clinical Trials, CDC Signs Off on RSV Shots for Newborns

Medical experts criticized the Centers for Disease Control and Prevention’s Thursday decision to recommend a “new immunization” for newborns to protect against respiratory syncytial virus, or RSV, calling the move

United statesNew yorkUnited kingdomPeter mcculloughGeorgina peacockHelen keipp talbotBrian hookerJefferson jonesRochelle walenskyGeorge reed grimesMandy cohenImmunization services divisionVanderbilt universityNew york timesCenters for diseaseDrug administration

Insulin Calculator Cleared; Twice-Rejected Diabetes Drug; Ozempic for Alcohol Use?

News and commentary from the endocrinology world

New yorkUnited statesResearchers at university of california san diegoEuropean medicines agencyAccu chek soloEndpoints newsCalifornia san diegoNew york city

Five things for pharma marketers to know: Friday, August 25, 2023

The CDC says it's too early to evaluate risk level of COVID subvariant; AbbVie drops two antibody-drug conjugates from pipeline.

Centers for diseaseDisease controlEndpoints news

vimarsana © 2020. All Rights Reserved.